Sino-Argi Leading Biosciences
Sino-Agri Leading Biosciences Co.,Ltd engages in pesticide distribution in China and internationally. The company sells technical materials, formulations, and related products. It also provides plant protection technology services; and crop health solutions, including technical guidance, application demonstration, and processing and packaging of plant protection products. In addition, the company… Read more
Sino-Argi Leading Biosciences (603970) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.227x
Based on the latest financial reports, Sino-Argi Leading Biosciences (603970) has a cash flow conversion efficiency ratio of -0.227x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-390.12 Million) by net assets (CN¥1.72 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Sino-Argi Leading Biosciences - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Sino-Argi Leading Biosciences's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Sino-Argi Leading Biosciences Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sino-Argi Leading Biosciences ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
John Mattson Fastighetsföretagen AB (publ)
F:AR5
|
0.008x |
|
D&L Industries Inc
PINK:DALQF
|
0.099x |
|
Evans Bancorp Inc
NYSE MKT:EVBN
|
-0.022x |
|
Hunan Zhenghong Science and Technology Develop Co Ltd
SHE:000702
|
-0.060x |
|
Alfen Beheer BV
AS:ALFEN
|
0.070x |
|
Fujian Fynex Textile Science & Technology Co Ltd
SHG:600493
|
-0.002x |
|
Indigo Paints Limited
NSE:INDIGOPNTS
|
0.027x |
|
United Arrows Ltd.
PINK:UTDAY
|
0.144x |
Annual Cash Flow Conversion Efficiency for Sino-Argi Leading Biosciences (2012–2024)
The table below shows the annual cash flow conversion efficiency of Sino-Argi Leading Biosciences from 2012 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.68 Billion | CN¥307.40 Million | 0.183x | +131.66% |
| 2023-12-31 | CN¥1.59 Billion | CN¥-919.85 Million | -0.577x | -155.78% |
| 2022-12-31 | CN¥1.48 Billion | CN¥1.54 Billion | 1.034x | +307.16% |
| 2021-12-31 | CN¥1.28 Billion | CN¥325.42 Million | 0.254x | -17.50% |
| 2020-12-31 | CN¥1.14 Billion | CN¥352.12 Million | 0.308x | +46.94% |
| 2019-12-31 | CN¥1.04 Billion | CN¥218.90 Million | 0.210x | +205.35% |
| 2018-12-31 | CN¥957.07 Million | CN¥65.69 Million | 0.069x | -88.54% |
| 2017-12-31 | CN¥866.35 Million | CN¥518.83 Million | 0.599x | +69.73% |
| 2016-12-31 | CN¥431.42 Million | CN¥152.22 Million | 0.353x | +147.82% |
| 2015-12-31 | CN¥344.56 Million | CN¥-254.22 Million | -0.738x | -630.24% |
| 2014-12-31 | CN¥290.44 Million | CN¥40.41 Million | 0.139x | +145.88% |
| 2013-12-31 | CN¥262.68 Million | CN¥-79.66 Million | -0.303x | -166.96% |
| 2012-12-31 | CN¥241.63 Million | CN¥109.43 Million | 0.453x | -- |